An update to "The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe"


Jit, M; Mangen, MJJ; Melliez, H; Yazdanpanah, Y; Bilcke, J; Salo, H; Edmunds, WJ; Beutels, P; (2010) An update to "The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe". Vaccine, 28 (47). pp. 7457-7459. ISSN 0264-410X DOI: 10.1016/j.vaccine.2010.08.060

Full text not available from this repository. (Request a copy)

Abstract

A cost-effectiveness analysis of rotavirus vaccination in Belgium, England and Wales, Finland, France and the Netherlands published in 2009 was updated based on recent studies on rotavirus burden of disease and vaccine efficacy. All the qualitative conclusions in the previous study were found to remain valid. Vaccination remains cost-effective in Finland only when using plausible tender prices. (C) 2010 Elsevier Ltd. All rights reserved.

Item Type: Article
Keywords: Rotavirus, Vaccination, Cost-effectiveness, GASTROENTERITIS, ROTARIX(TM), EFFICACY, RIX4414, INFANTS
Faculty and Department: Faculty of Epidemiology and Population Health > Dept of Infectious Disease Epidemiology
Research Centre: Vaccine Centre
PubMed ID: 20846529
Web of Science ID: 284435500003
URI: http://researchonline.lshtm.ac.uk/id/eprint/1894

Statistics


Download activity - last 12 months
Downloads since deposit
0Downloads
293Hits
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item